has been cited by the following article(s):
|
[1]
|
Newer modalities in the management of Alzheimer's dementia along with the role of aducanumab and lecanemab in the treatment of its refractory cases
Disease-a-Month,
2023
DOI:10.1016/j.disamonth.2023.101547
|
|
|
|
|
[2]
|
Newer modalities in the management of Alzheimer's dementia along with the role of aducanumab and lecanemab in the treatment of its refractory cases
Disease-a-Month,
2023
DOI:10.1016/j.disamonth.2023.101547
|
|
|
|
|
[3]
|
A novel method to improve the osteogenesis capacity of hUCMSCs with dual‐directional pre‐induction under screened co‐culture conditions
Cell Proliferation,
2020
DOI:10.1111/cpr.12740
|
|
|
|
|
[4]
|
A novel method to improve the osteogenesis capacity of hUCMSCs with dual‐directional pre‐induction under screened co‐culture conditions
Cell Proliferation,
2020
DOI:10.1111/cpr.12740
|
|
|
|
|
[5]
|
New treatment modalities in Alzheimer's disease
World Journal of Clinical Cases,
2019
DOI:10.12998/wjcc.v7.i14.1764
|
|
|
|
|
[6]
|
Advances in Experimental Medicine and Biology,
2018
DOI:10.1007/5584_2018_214
|
|
|
|
|
[7]
|
Stem cell therapy in Alzheimer’s disease: possible benefits and limiting drawbacks
Molecular Biology Reports,
2018
DOI:10.1007/s11033-018-4499-7
|
|
|
|
|
[8]
|
Moving from the Dish to the Clinical Practice: A Decade of Lessons and Perspectives from the Pre-Clinical and Clinical Stem Cell Studies for Alzheimer’s Disease
Journal of Alzheimer's Disease,
2016
DOI:10.3233/JAD-160250
|
|
|
|